← FDA Drug Approvals (Drugs@FDA)
SUCRALFATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS · Approved 2022-04-15
Drug application
- FDA Application #
ANDA215576- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SUCRALFATE
- Generic name
- SUCRALFATE
- Active ingredients
- SUCRALFATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AMNEAL PHARMS
- Manufacturer
- Amneal Pharmaceuticals NY LLC
- First approval
- 2022-04-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown